Dabei Cai
Overview
Explore the profile of Dabei Cai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
50
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wei J, Cai D, Xiao T, Chen Q, Zhu W, Gu Q, et al.
Heliyon
. 2024 Sep;
10(16):e36051.
PMID: 39224361
Objective: This study aimed to develop and validate several artificial intelligence (AI) models to identify acute myocardial infarction (AMI) patients at an increased risk of acute kidney injury (AKI) during...
2.
Gu Q, Deng Y, Wei J, Chen Q, Cai D, Xiao T, et al.
Clin Cardiol
. 2024 May;
47(6):e24276.
PMID: 38812437
Background: The purpose of this study was to explore the association between triglycerides (TGs) and the risk of atrial fibrillation (AF) recurrence. Methods And Results: Included were adult patients with...
3.
Cai D, Xiao T, Chen Q, Gu Q, Wang Y, Ji Y, et al.
BMC Cardiovasc Disord
. 2024 Apr;
24(1):216.
PMID: 38643093
Background: Acute kidney injury (AKI) in patients with acute myocardial infarction (AMI) often indicates a poor prognosis. Objective: This study aimed to investigate the association between the TyG index and...
4.
Zou A, Xiao T, Chi B, Wang Y, Mao L, Cai D, et al.
Int J Nanomedicine
. 2024 Apr;
19:3295-3314.
PMID: 38606373
Background: Cardiac repair remains a thorny issue for survivors of acute myocardial infarction (AMI), due to the regenerative inertia of myocardial cells. Cell-free therapies, such as exosome transplantation, have become...
5.
Chen Q, Gu Q, Yin A, Cai D, Xiao T, Wang Y, et al.
Clin Interv Aging
. 2024 Mar;
19:503-515.
PMID: 38525316
Objective: This study aimed to explore the association of preoperative neutrophil percentage (NEUT%) with the risk of acute kidney injury (AKI) in patients with acute myocardial infarction (AMI) having undergone...
6.
Cai D, Chen Q, Mao L, Xiao T, Wang Y, Gu Q, et al.
Eur J Clin Pharmacol
. 2024 Feb;
80(4):613-620.
PMID: 38319348
Objective: Sodium-glucose cotransporter 2 (SGLT2) inhibitors have well-documented effects in reducing hospitalization or cardiovascular mortality, while the association of SGLT2 inhibitor dapagliflozin (DAPA) and the risk of acute kidney injury...
7.
Xiao T, Wei J, Cai D, Wang Y, Cui Z, Chen Q, et al.
Biomed Pharmacother
. 2024 Feb;
172:116224.
PMID: 38308970
Objective: Extracellular vesicles (EVs) have garnered considerable attention among researchers as candidates for natural drug delivery systems. This study aimed to investigate whether extracellular vesicle mediated targeting delivery of growth...
8.
Cai D, Chen Q, Mu X, Xiao T, Gu Q, Wang Y, et al.
BMC Cardiovasc Disord
. 2024 Jan;
24(1):16.
PMID: 38172656
Background: The purpose of this study was to develop a Nomogram model to identify the risk of all-cause mortality during hospitalization in patients with heart failure (HF). Methods: HF patients...
9.
Mao L, Cai D, Chi B, Xiao T, Zou A, Wang Y, et al.
Eur J Clin Pharmacol
. 2023 Apr;
79(7):915-926.
PMID: 37099214
Objective: The aim of this study was to investigate the effect of dapagliflozin (DAPA) on the rate of heart failure rehospitalization in patients with acute myocardial infarction (AMI) and type...
10.
Sun L, Ji Y, Chi B, Xiao T, Li C, Yan X, et al.
Biomed Pharmacother
. 2023 Mar;
161:114557.
PMID: 36963364
Background: Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs), due to their inner functional substances, have shown great value in treating acute myocardial infarction (AMI). However, their clinical application...